References
- Weibrecht K, Dayno MDarling C, et al. Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injury. J Med Toxicol. 2010;6(3):294–300.
- Daniele C, Thompson Coon JPittler MH, et al. Vitex agnus castus: a systematic review of adverse events. Drug Saf. 2005;28(4):319–332.
- Chen S-N, Friesen JB, Webster D, et al. Phytoconstituents from vitex agnus-castus fruits. Fitoterapia. 2011;82.4:528–533. PMC. Web. 2018 Sept 23.
- Dennis JM, Witting PK. Protective role for antioxidants in acute kidney disease. Nutrients. 2018 Sept 23;9.7(2017):718. PMC. Web.
- Panizo N, Rubio-Navarro A, Amaro-Villalobos J,M, et al. Molecular mechanisms and novel therapeutic approaches to rhabdomyolysis-induced acute kidney injury. Kidney Blood Press Res. 2015;40:520–532.
- Gabadri S, Munz K, Ulbricht C. A review of dietary supplement induced renal dysfunction. Clin J Am Soc Nephrol. 2007;2(4):757–765.
- Yang B, Xie Y, Guo M, et al. Nephrotoxicity and chinese herbal medicine. Clin J Am Soc Nephrol. 2018;13:1–7.
- Rhabdomyolysis. Natural medicines. Ann arbor (MI). Truven Health Analytics; 2018. Accessed 2018 Sept 20.
- Palmer ME MD, Haller C MD, McKinney PE, et al. Adverse events associated with dietary supplements: an observational study; 2003, January 10. Available from: https://www.sciencedirect.com/science/article/pii/S0140673603122271
- Qato DM. Use of prescription and over-the-counter medications and dietary supplements among older adults in the USA; 2008, December 24. Available from: https://jamanetwork.com/journals/jama/fullarticle/183125